本帖最后由 成长的烦恼 于 2012-6-27 20:19 编辑
* c2 x- B$ j4 V& \
! d# X' \& W: p5 d; Uclinicaltrials上的三期临床链接
% e D: L" W! [/ f
& I2 V3 o5 n. t! u3 B0 {: u( {http://clinicaltrials.gov/ct2/sh ... mp;show_locs=Y#locn- t' [; g, D$ G; P) `: q2 z
1 |" R, e! [% V中国参加临床实验的城市
2 Z( E) p; ]% {' u" q" D) a6 a+ B9 w3 z) d5 T# T4 P
China, Guangdong 8 P {+ z, T3 ~6 k/ U
& J7 ~% k! V( _9 Q9 K# N' X
Guangzhou, Guangdong, China, 510515 8 {* O9 I5 y0 Q$ f9 h$ m% ^4 K# x0 M
" k! n1 v3 u! @. [ k- c d
Guangzhou, Guangdong, China, 510060
" n- Q- E# d8 V J1 WChina, Jiangsu
8 g8 @ }8 j9 h* y 0 Y( I2 C1 ?) `7 {. y
Nanjing, Jiangsu, China, 210009 1 c; J1 q+ W" M0 o& t$ z
7 y) _9 \2 l' @' O7 d! Y' o" P
Nanjing, Jiangsu, China, 210002 ! T; [) |) d. l2 Y2 `5 d$ W, K( w
China, Shandong
5 R& z$ k+ q) {2 { k$ b8 Z3 a * W$ T4 r! O% q+ P6 }
Qingdao, Shandong, China, 266003
" w1 p, c$ A" m4 s- Y5 vChina
4 k0 R9 M, G. _, F) b6 D# L
" |+ I' w" C! p/ PBeijing, China, 100021
) n$ c2 X( v6 g |& _0 y2 T % ~- q/ e! B0 f8 Q) F% t
Beijing, China, 100071
4 ?6 e4 _5 @; L
- N Z; `9 S4 C% }" ~' K: TChangchun, China, 130021
1 s2 a4 z- f* T P+ Q) m6 Z* v( e0 v( R! H% P
Chongqing, China, 400042
+ W8 O9 L/ S& m1 \6 W' H
& w9 A' P4 p% W8 SChongqing, China, 400038 1 ?, U( B# F" b+ w
- Y1 y( `/ u; qFuzhou, China, 350014
+ `# S2 C* `) i5 j/ o2 h
* }/ d9 \/ Z K& w3 Q0 G. rFuzhou, China, 350025 ; \" S: e ^6 Z5 ~4 c
, j, x0 L/ C/ [0 ]Ha'erbin, China, 150040 $ V: l. m2 F9 U
. |4 O# f( C- e* ]- a2 G
Hanghzou, China, 310009 % Q$ s7 Q$ D* Q' J8 |
; D M% L2 a& b( G5 Q/ a2 `7 h* Q/ r
Shanghai, China, 200001
: |! T8 ~" \% N$ L% U # A0 [. b! w4 e: q6 Y4 I
Shanghai, China, 200030
1 d$ c6 S! [8 _; O# Z5 }
: ?% ]; D5 }. c- T5 j/ xTianjin, China
, ~5 O# L2 z# r, ~7 f0 J: k; V! U1 {! ?# O9 M
该实验已停止招募,重新开的临床请见临床专用贴。 |